Agenus provided an execution update on its ROBBIN Phase 3 trial and outlined progress in its BOT+BAL immunotherapy program for colorectal cancer. It also detailed the case for pre-surgery immunotherapy; a stakeholder webcast replay is available.
published
Agenus provided an execution update on its ROBBIN Phase 3 trial and outlined progress in its BOT+BAL immunotherapy program for colorectal cancer. It also detailed the case for pre-surgery immunotherapy; a stakeholder webcast replay is available.
Latest documented BWB result
$META market result
I sold the $META $655 Puts 9/25 for $7.60
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.